Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Celldex Therapeutics (CLDX)

Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Celldex: Q4 Earnings Snapshot

Celldex: Q4 Earnings Snapshot

CLDX : 37.77 (-2.78%)
Why Celldex Therapeutics Blasted 13% Higher on Monday

The biotech's CSU treatment advanced in the laboratory.

CLDX : 37.77 (-2.78%)
Freshpet, Celldex Therapeutics rise; TreeHouse Foods, Dish Network fall, Monday, 11/6/2023

Stocks that traded heavily or had substantial price changes on Monday: Freshpet, Celldex Therapeutics rise; TreeHouse Foods, Dish Network fall

CLDX : 37.77 (-2.78%)
THS : 36.69 (+0.05%)
HGV : 44.64 (+1.87%)
DISH : 5.77 (+1.94%)
FRPT : 105.24 (+0.47%)
Celldex: Q3 Earnings Snapshot

Celldex: Q3 Earnings Snapshot

CLDX : 37.77 (-2.78%)
Celldex: Q2 Earnings Snapshot

Celldex: Q2 Earnings Snapshot

CLDX : 37.77 (-2.78%)
Celldex Therapeutics (CLDX) Reports Q1 Loss, Tops Revenue Estimates

Celldex (CLDX) delivered earnings and revenue surprises of 1.59% and 157.87%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

CLDX : 37.77 (-2.78%)
TFFP : 2.97 (+15.12%)
Celldex: Q1 Earnings Snapshot

Celldex: Q1 Earnings Snapshot

CLDX : 37.77 (-2.78%)
Strength Seen in Celldex (CLDX): Can Its 7.1% Jump Turn into More Strength?

Celldex (CLDX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road....

CLDX : 37.77 (-2.78%)
ICPT : 19.00 (+0.21%)
Celldex: Q4 Earnings Snapshot

Celldex: Q4 Earnings Snapshot

CLDX : 37.77 (-2.78%)
Celldex Therapeutics (CLDX) Reports Q3 Loss, Tops Revenue Estimates

Celldex (CLDX) delivered earnings and revenue surprises of 0% and 62.80%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

CLDX : 37.77 (-2.78%)
AFMD : 5.35 (+7.00%)

Barchart Exclusives

Nasdaq Futures Climb on Tesla Boost, Meta Earnings in Focus
June Nasdaq 100 E-Mini futures (NQM24) are trending up +0.53% this morning as Tesla surged on new EV promises and investors looked ahead to the next round of corporate earnings. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar